**UNITED        STATES**

**SECURITIES        AND EXCHANGE COMMISSION**

**Washington,        D.C. 20549**

**FORM        10-QSB**

| [X]                  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES                  EXCHANGE ACT OF 1934                   |
|-------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                            | For                  the quarterly period ended March 31, 2005 |
|                                                                                                                                            |   |
|                                                                                                                                            |   |
| [                  ]                  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES                  EXCHANGE ACT OF 1934 |
|                                                                                                                                            | For                  the transition period from _________to___________ |
|                                                                                                                                            | Commission                  file number: 000-29915 |

**BIO        TRACKING SECURITY, INC. **

----

| Florida                                                                                          |   | 65-0786722                                            |
|--------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------|
| (State                  or other jurisdiction of incorporation or                  organization) |   | (I.R.S.                  Employer Identification No.) |

| 1                  Place Ville Marie, Suite 2821, Montreal, Quebec, Canada | H3B                  4R4    |
|----------------------------------------------------------------------------|-----------------------------|
| (Address                  of principal executive offices)                  | (Zip                  Code) |

----

**BIO        TRACKING SECURITY, INC.**

| Description                                                                                                                                       | Page                                                                                                                                                                                                                                                       |
|---------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| **PART                  I. FINANCIAL INFORMATION**                                                                                                |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| Item                  1. Financial Statements (unaudited)                                                                                         |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
|                                                                                                                                              | *Consolidated                  interim balance sheets at December 31, 2005                  (unaudited)*                                                                                                                                                   | F-1 |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
|                                                                                                                                              | *Consolidated                  interim statements of operations and comprehensive income (loss)                  for the                  three months ended December 31, 2005 and 2004 and from inception to                  March 31, 2005 (unaudited)* | F-2 |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
|                                                                                                                                              | *Consolidated                  interim statements of stockholders deficiency from inception to                  March 31,                  2005 (unaudited)*                                                                                               | F-3 |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
|                                                                                                                                              | *Consolidated                  interim statements of cash flows for the three months ended December                  31, 2005 and 2004 and from inception to March 31, 2005                  (unaudited)*                                                  | F-4 |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
|                                                                                                                                              | *Notes                  to consolidated condensed financial statements for the three months                  ended June 30, 2005 and 2004 (unaudited)*                                                                                                     | F-5 |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| Item                  2. Management's Discussion and Analysis of Financial Conditions                  and                  Results of Operations | 1                                                                                                                                                                                                                                                          |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| Item                  3. Controls and Procedures                                                                                                  | 3                                                                                                                                                                                                                                                          |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| **PART                  II. OTHER INFORMATION**                                                                                                   |                                                                                                                                                                                                                                                       |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| Item                  1. Legal Proceedings                                                                                                        | 4                                                                                                                                                                                                                                                          |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| Item                  2. Unregistered Sales of Equity Securities and Use of                  Proceeds                                             | 4                                                                                                                                                                                                                                                          |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| Item                  3. Defaults Upon Senior Securities                                                                                          | 4                                                                                                                                                                                                                                                          |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| Item                  4. Submission of Matters to a Vote of Security Holders                                                                      | 4                                                                                                                                                                                                                                                          |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| Item                  5. Other Information                                                                                                        | 4                                                                                                                                                                                                                                                          |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| Item                  6. Exhibits and Reports on Form 8-K                                                                                         | 4                                                                                                                                                                                                                                                          |
|                                                                                                                                              |                                                                                                                                                                                                                                                       |   |
| SIGNATURES                                                                                                                                        | 5                                                                                                                                                                                                                                                          |

----

**BIO        TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND        SUBSIDIARY**

**(A        DEVELOPMENT STAGE COMPANY)**

**CONSOLIDATED        INTERIM BALANCE SHEET**

**(UNAUDITED)**

|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |       |                                |          |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-------------------------------------|---------------|
|                                                                                  |       | **MARCH                  31, 2005** | ** **    |
| ** **                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | ** ** | **U.S.                  $**         |          |
| **ASSETS**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |       |                                |          |
| **CURRENT                  ASSETS**                                                                                                                                                                                                                                                                                                                                                                                                                                                              |       |                                |          |
| Cash                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |       |                                | 58            |   |
| R&D                  Refundable Tax Credits                                                                                                                                                                                                                                                                                                                                                                                                                                                  |       |                                | 212,308       |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |       |                                |          |   |
| Total                  Current Assets                                                                                                                                                                                                                                                                                                                                                                                                                                                            |       |                                | **212,366**   |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |       |                                |          |   |
| Fixed                  Assets                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |       |                                | 19,750        |   |
| Goodwill                  (Note 7)                                                                                                                                                                                                                                                                                                                                                                                                                                                               |       |                                | 4,762,020     |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| **Total                  Assets**                                                                                                                                                                                                                                                                                                                                                                                                                                                                |       |                                | **4,994,136** |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| **LIABILITIES                  AND SHAREHOLDERS' EQUITY**                                                                                                                                                                                                                                                                                                                                                                                                                                        |       |                                |          |   |
| **CURRENT                  LIABILITIES**                                                                                                                                                                                                                                                                                                                                                                                                                                                         |       |                                |          |   |
| Accounts                  Payable                                                                                                                                                                                                                                                                                                                                                                                                                                                                |       |                                | 85,000        |   |
| Due                  to Officers and Employees                                                                                                                                                                                                                                                                                                                                                                                                                                                   |       |                                | 98,274        |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| **Total                  Current Liabilities**                                                                                                                                                                                                                                                                                                                                                                                                                                                   |       |                                | **183,274**   |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| **STOCKHOLDERS'                  EQUITY:**                                                                                                                                                                                                                                                                                                                                                                                                                                                       |       |                                |          |   |
| Common                  stock, $0.001 par value; authorized 500,000,000 shares;30,000,000                  preferred issued and outstanding 337,865,401 shares                                                                                                                                                                                                                                                                                                                                   |       |                                | 337,866       |   |
| Paid-in                  capital                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |       |                                | 6,815,147     |   |
| Accumulated                  deficit during development stage                                                                                                                                                                                                                                                                                                                                                                                                                                    |       |                                | (2,342,151    | ) |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Total                  Stockholders Equity                                                                                                                                                                                                                                                                                                                                                                                                                                                       |       |                                | 4,810,862     |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| **Total                  Liabilities and Stockholders' Equity**                                                                                                                                                                                                                                                                                                                                                                                                                                  |       |                                | **4,994,136** |   |

----

**BIO        TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND        SUBSIDIARY**

**(A        DEVELOPMENT STAGE COMPANY)**

**CONSOLIDATED        INTERIM STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME        (LOSS)**

**(UNAUDITED)**

|                                                          |   | FOR                        THE PERIODJANUARY                        1, 2005MARCH                        31, 2005 |        | FOR                        THE PERIODJANUARY                        1, 2004MARCH                        31, 2004 |   | FOR                        THE PERIODOCT.                        19, 2000MARCH                        31, 2005 |   |
|---------------------------------------------------------------|--------|------------------------------------------------------------------------------------------------------------------|-------------|------------------------------------------------------------------------------------------------------------------|--------|----------------------------------------------------------------------------------------------------------------|--------|
|                                                          |   | **U.S.$**                                                                                                        |        | **U.S.$**                                                                                                        |   | **U.S.$**                                                                                                      |   |
|                                                          |   |
| **Sales**                                                     |   |                                                                                                             |        |                                                                                                             |   |                                                                                                           |   |
| **Income**                                                    |   |                                                                                                             | --          |                                                                                                             |   | --                                                                                                             |   |   | 34,616 |   |
|                                                          |   |                                                                                                             |        |                                                                                                             |   |                                                                                                           |   |   |   |   |
| **Expenses**                                                  |   |                                                                                                             |        |                                                                                                             |   |                                                                                                           |   |   |   |   |
|                                                          |   |                                                                                                             |        |                                                                                                             |   |                                                                                                           |   |   |   |   |
| Selling,                        general and administrative    |   |                                                                                                             | 1,313       |                                                                                                             |   | 50,002                                                                                                         |   |   | (2,226,789 | ) |
|                                                          |   |                                                                                                             |        |                                                                                                             |   |                                                                                                           |   |   |   |   |
| Loss                        before Provision for Income Taxes |   |                                                                                                             | 1,313       |                                                                                                             |   | (50,002                                                                                                        | )      |   | (2,192,173 | ) |
|                                                          |   |                                                                                                             |        |                                                                                                             |   |                                                                                                           |   |   |   |   |
| Provision                        for Income Taxes             |   |                                                                                                             | --          |                                                                                                             |   | --                                                                                                             |   |   | -- |   |
|                                                          |   |                                                                                                             |        |                                                                                                             |   |                                                                                                           |   |   |   |   |
| Comprehensive                        Net (Loss)               |   |                                                                                                             | (1,313      | )                                                                                                                |   | (50,002                                                                                                        | )      |   | (2,192,173 | ) |
|                                                          |   |                                                                                                             |        |                                                                                                             |   |                                                                                                           |   |   |   |   |
| Net                        Loss Per Common Share              |   |                                                                                                             | (0.00       | )                                                                                                                |   | (0.00                                                                                                          | )      |   | (0.00 | ) |
| Fully                        Diluted                          |   |                                                                                                             | (0.00       | )                                                                                                                |   | (0.00                                                                                                          | )      |   | (0.00 | ) |
| Weighted                        Average Common Shares         |   |                                                                                                             |        |                                                                                                             |   |                                                                                                           |   |   |   |   |
| Outstanding                                                   |   |                                                                                                             | 337,865,401 |                                                                                                             |   | 337,865,401                                                                                                    |   |   | 337,865,401 |   |
| Fully                        Weighted Average Common          |   |                                                                                                             |        |                                                                                                             |   |                                                                                                           |   |   |   |   |
| Shares                        Outstanding                     |   |                                                                                                             | 353,905,735 |                                                                                                             |   | 353,905,735                                                                                                    |   |   | 353,905,735 |   |

----

**BIO        TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND        SUBSIDIARY**

**(A        DEVELOPMENT STAGE COMPANY)**

**(UNAUDITED)**

**CONSOLIDATED        INTERIM STATEMENTS OF STOCKHOLDERS’ DEFICIENCY**

**FOR        THE PERIOD FROM OCTOBER 19, 2000 TO MARCH 31, 2005**

|   |   | Shares |                                  | US$CommonStockAmount |                                  | US$AdditionalPaid-N-Capital |                                  | US$AccumulatedDeficitDuringDevelopmentState |                                  | US$TotalStockholdersDeficiencies |                          |
|--------|--------|--------|----------------------------------------------------------------|----------------------|----------------------------------------------------------------|-----------------------------|----------------------------------------------------------------|---------------------------------------------|----------------------------------------------------------------|----------------------------------|------------------------------------|

| Balance                    June 30, 2004                                  |   |   | 337,865,401     |       |       | 337,866     |       |       | 6,815,147     |       |       | (2,282,975     | )      |       | 4,870,038     |   |
|---------------------------------------------------------------------------|--------|--------|-----------------|------------|------------|-------------|------------|------------|---------------|------------|------------|----------------|--------|------------|---------------|--------|
| Loss                        for the Period July 1, 2004 to March 31, 2005 |   |   | --              |       |       | --          |       |       | --            |       |       | (59,176        | )      |       | (59,176       | )      |
|                                                                      |   |   |            |       |       |        |       |       |          |       |       |           |   |       |          |   |
| Balance                    March 31, 2005                                 |   |   | **337,865,401** | ** ** | ** ** | **337,866** | ** ** | ** ** | **6,815,147** | ** ** | ** ** | **(2,342,151** | **)**  | ** ** | **4,810,862** |   |

----

**BIO        TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND        SUBSIDIARY**

**(A        DEVELOPMENT STAGE COMPANY)**

**(UNAUDITED)**

**CONSOLIDATED        INTERIM STATEMENTS OF CASH FLOWS**

|        |   | FOR                        THE PERIODJANUARY                        1, 2005MARCH                        31, 2005 |   | FOR                        THE PERIODJANUARY                        1, 2004MARCH                        31, 2004 |   | FOR                        THE PERIODOCT.                        19, 2000MARCH                        31, 2005 |   |
|--------|--------|------------------------------------------------------------------------------------------------------------------|--------|------------------------------------------------------------------------------------------------------------------|--------|----------------------------------------------------------------------------------------------------------------|--------|
|   |   | **U.S.$**                                                                                                        |   | **U.S.$**                                                                                                        |   | **U.S.$**                                                                                                      |   |

| **Cash                        Flows from Operating Activities:**                                                           |   |   |   |   |   |          |   |
|----------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|--------|--------|---------------|--------|
| Net                        Loss                                                                                            |   |   | (1,313 | )      |   | (50,002       | )      |   | (2,342,151 | ) |
| Adjustments                        to reconcile net loss to net                                                            |   |   |   |   |   |          |   |   |   |   |
| cash                        used for operating activities:                                                                 |   |   |   |   |   |          |   |   |   |   |
| Depreciation                        and amortization                                                                       |   |   | 1,100  |   |   | --            |   |   | 38,682 |   |
| R&D                        Refundable Tax Credit                                                                       |   |   | --     |   |   | --            |   |   | (212,308 | ) |
| Sales                        tax receivable                                                                                |   |   | --     |   |   | 6,388         |   |   | -- |   |
| Accounts                        payable                                                                                    |   |   | --     |   |   | (402872       | )      |   | 85,000 |   |
| Amounts                        due to officers                                                                             |   |   | --     |   |   | 35,505        |   |   | 98,274 |   |
| Loss                        on Disposal of Assets                                                                          |   |   | --     |   |   | --            |   |   | 121,563 |   |
|                                                                                                                       |
| **Net                        Cash and Cash Equivalents Provided by (Used in) Operating                        Activities** |   |   | (213   | )      |   | (210,981      | )      |   | (2,210,940 | ) |
|                                                                                                                       |
| **Cash                        Flows from Investing Activities**                                                            |   |   |   |   |   |          |   |   |   |   |
| Purchase                        of Goodwill                                                                                |   |   | --     |   |   | (4,562,020    | )      |   | (4,762,020 | ) |
| Purchase                        of Capital Assets                                                                          |   |   | --     |   |   | --            |   |   | (211,070 | ) |
|                                                                                                                       |
| **Net                        Cash Used for Investing Activities**                                                          |   |   | **--** |   |   | (4,562,020    | )      |   | (4,973,090 | ) |
|                                                                                                                       |
| **Cash                        Flows from Financing Activities:**                                                           |   |   |   |   |   |          |   |   |   |   |
| Write-off                        deficit to Paid-in-Capital                                                                |   |   | --     |   |   | --            |   |   | 139,877 |   |
| Write-off                        comprehensive income to Paid Capital                                                      |   |   | --     |   |   | --            |   |   | 10,807 |   |
| Write-off                        stock subscription receivable                                                             |   |   | --     |   |   | --            |   |   | 196,349 |   |
| Decrease                        in short term loans                                                                        |   |   | --     |   |   | --            |   |   | -- |   |
| (Decrease)                        in loans-related party                                                                   |   |   | --     |   |   | --            |   |   | -- |   |
| (Decrease)                        Increase in loans payable (Note 7)                                                       |   |   | --     |   |   | (868,579      | )      |   | -- |   |
| Increase                        in capital stock                                                                           |   |   | --     |   |   | 197,480       |   |   | 221,963 |   |
| Increase                        in paid-in capital                                                                         |   |   | --     |   |   | 5,439,716     |   |   | 6,615,092 |   |
|                                                                                                                       |
| **Net                        Cash from Financing Activities**                                                              |   |   | **--** |   |   | **4,768,617** |   |   | **7,184,088** |   |
|                                                                                                                       |
| Net                        (Decrease) Increase in Cash                                                                     |   |   | (213   | )      |   | (4,384        | )      |   | 58 |   |
| Cash                        - Beginning of Period                                                                          |   |   | 271    |   |   | 5,000         |   |   | -- |   |
|                                                                                                                       |
| Cash                        - End of Period                                                                                |   |   | 58     |   |   | 616           |   |   | 58 |   |
|                                                                                                                       |
| **Supplemental                        Disclosure of Non-Cash Flow Information:**                                           |   |   |   |   |   |          |   |   |   |   |
| Cash                        paid during the Year for:                                                                      |   |   |   |   |   |          |   |   |   |   |
| Interest                                                                                                                   |   |   | --     |   |   | --            |   |   | -- |   |
| Income                        Taxes                                                                                        |   |   | --     |   |   | --            |   |   | -- |   |
|                                                                                                                       |   |   |   |   |   |          |   |   |   |   |
|                                                                                                                       |   |   | --     |   |   | --            |   |   | -- |   |

----

**BIO        TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND        SUBSIDIARY**

**(A        DEVELOPMENT STAGE COMPANY)**

**INTERIM        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**AS        AT MARCH 31, 2005**

**1.    **
**BACKGROUND        AND ORGANIZATION**

**2.    **
**ACCOUNTING        POLICIES**

**Basis        of Presentation**

**Principles        of Consolidation**

**Cash        and Cash Equivalent**

**Furniture,        Fixtures and Equipment**

----

**BIO        TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND        SUBSIDIARY**

**(A        DEVELOPMENT STAGE COMPANY)**

**INTERIM        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**AS        AT MARCH 31, 2005**

**Income        Taxes**

**Earnings        Per Share**

**Use        of Estimates**

**Fair        Value Disclosure at March 31, 2005**

**Effect        of New Accounting Standards**

----

**BIO        TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND        SUBSIDIARY**

**(A        DEVELOPMENT STAGE COMPANY)**

**INTERIM        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**AS        AT MARCH 31, 2005**

**Effect        of New Accounting Standards**

**3.    GOING        CONCERN**

**4.    PROVISION        FOR        INCOME TAX**

**5.    COMMITMENTS        AND CONTINGENCIES **

**Insurance**

**Contingencies**

**6.    REDUCTION        OF        LOAN OUTSTANDING**

----

**BIO        TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND        SUBSIDIARY**

**(A        DEVELOPMENT STAGE COMPANY)**

**INTERIM        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**AS        AT MARCH 31, 2005**

**7.    GOODWILL**

**8.    **SUBSEQUENT        EVENTS****

**Significant        Changes to Key Management and Share Capital Management        Changes**

----

**BIO        TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND        SUBSIDIARY**

**(A        DEVELOPMENT STAGE COMPANY)**

**INTERIM        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**AS        AT MARCH 31, 2005**

**Changes        in Share Capital**

----

**Item        2. Management's Discussion and Analysis of Financial Condition and Results        of        Operations**

*Statements        included in this Management's Discussion and Analysis of Financial Condition        and        Results of Operations, and in future filings by the company with the Securities        and Exchange Commission, in the company's press releases and in oral statements        made with the approval of an authorized executive officer which are not        historical nor current facts are "forward-looking statements" and are subject        to        certain risks and uncertainties that could cause actual results to differ        materially from historical earnings and those presently anticipated or        projected. Without limiting the generality of the foregoing, words such as        "may,"  "will,"  "expect,"  "believe,"  "anticipate,"         "intend,"  "could,"  "estimate," or "continue" or the negative        or        other variations thereof or comparable terminology are intended to identify        forward-looking statements. The foregoing list should not be construed as        exhaustive and the company disclaims any obligation subsequently to revise        any        forward-looking statements to reflect events or circumstances after the date        of        such statements or to reflect the occurrence of anticipated or unanticipated        events. You are cautioned not to place undue reliance on any such        forward-looking statements, which speak only as of the date made. The following        important factors, among others, in some cases have affected and in the future        could affect the our actual results and could cause the our actual financial        performance to differ materially from that expressed in any forward-looking        statement: (i) the extremely competitive conditions that currently exist        in the        market for companies similar to us; (ii) lack or resources to maintain the        company's good standing status and requisite filings with the Securities        and        Exchange Commission; (iii) history of operating losses and accumulated deficit;        (iv) possible need for additional financing; and (v) other factors discussed        in        this report and the Company's other filings with the Securities and Exchange        Commission. The following discussion should be read in conjunction with our        financial statements and their explanatory notes included in the        report.*

**Summary**

----

** Operations        **

**Capital        Needs **

**Results        of Operations**

|                                                    |   | FOR                  THE PERIODJANUARY                  1, 2005MARCH                  31, 2005 |   | FOR                  THE PERIODJANUARY                  1, 2004MARCH                  31, 2004 |   | FOR                  THE PERIODOCT.                  19, 2000MARCH                  31, 2005 |   |
|---------------------------------------------------------|--------|------------------------------------------------------------------------------------------------|--------|------------------------------------------------------------------------------------------------|--------|----------------------------------------------------------------------------------------------|--------|
|                                                    |   | **U.S.$**                                                                                      |   | **U.S.$**                                                                                      |   | **U.S.$**                                                                                    |   |
|                                                    |   |
| **Sales**                                               |   |                                                                                           |   |                                                                                           |   |                                                                                         |   |
| **Income**                                              |   |                                                                                           | --     |                                                                                           |   | --                                                                                           |   |   | 34,616 |   |
|                                                    |   |                                                                                           |   |                                                                                           |   |                                                                                         |   |   |   |   |
| **Expenses**                                            |   |                                                                                           |   |                                                                                           |   |                                                                                         |   |   |   |   |
|                                                    |   |                                                                                           |   |                                                                                           |   |                                                                                         |   |   |   |   |
| Selling,                  general and administrative    |   |                                                                                           | 1,313  |                                                                                           |   | 50,002                                                                                       |   |   | (2,226,789 | ) |
|                                                    |   |                                                                                           |   |                                                                                           |   |                                                                                         |   |   |   |   |
| Loss                  before Provision for Income Taxes |   |                                                                                           | 1,313  |                                                                                           |   | (50,002                                                                                      | )      |   | (2,192,173 | ) |
|                                                    |   |                                                                                           |   |                                                                                           |   |                                                                                         |   |   |   |   |
| Provision                  for Income Taxes             |   |                                                                                           | --     |                                                                                           |   | --                                                                                           |   |   | -- |   |
|                                                    |   |                                                                                           |   |                                                                                           |   |                                                                                         |   |   |   |   |
| Comprehensive                  Net (Loss)               |   |                                                                                           | (1,313 | )                                                                                              |   | (50,002                                                                                      | )      |   | (2,192,173 | ) |

**RISK        FACTORS **

**FACTORS        THAT COULD AFFECT FUTURE RESULTS **

**Liquidity        and Capital Resources**

----

**ACCOUNTING        POLICIES SUBJECT TO ESTIMATION AND JUDGMENT**

**ITEM        3. EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES**

----

**PART        II. OTHER INFORMATION**

**Item        1. Legal Proceedings**

**Item        2. **
**Unregistered        Sales of Equity Securities and Use of Proceeds **

**Item        3. Defaults upon Senior Securities**

**Item        4. Submission of Matters to a Vote of Security Holders**

**Item        5. Other Information**

**Item        6. Exhibits and Reports on Form 8-K**

**A.        Exhibits**

----

**SIGNATURES**

|                                        |                                                                                                   |                                          |
|---------------------------------------------|--------------------------------------------------------------------------------------------------------|-----------------------------------------------|
|                                        | **BIO-TRACKING                  SECURITY SYSTEMS, INC.**                                               |
|                                   |                                                                                              |                                     |
| Date: October                  6, 2005 | By:                                                                                          | /s/ Jean-Francois                  Amyot |
|                                        | Name: Jean-Francois                  Amyot                                                        |
|                                        | Title: Chief                    Executive Officer(Principal                    Executive Officer) |

|                                      |                                                                                                                          |                                        |
|-------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------|
| Date: October                6, 2005 | By:                                                                                                                 | /s/ Jean-Francois                Amyot |
|                                      | Name: Jean-Francois                Amyot                                                                                 |
|                                      | Title:                    Chief                  Accounting Officer (Principal                  Accounting Officer) |

----